Form 8-K - Current report:
SEC Accession No. 0001645113-24-000002
Filing Date
2024-01-04
Accepted
2024-01-04 16:10:24
Documents
15
Period of Report
2024-01-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20240104.htm   iXBRL 8-K 37524
2 EX-10.1 ex101leonardemploymentagre.htm EX-10.1 120965
3 EX-10.2 ex102shahemploymentagreeme.htm EX-10.2 114949
4 EX-99.1 managementupdatejanuary420.htm EX-99.1 10413
  Complete submission text file 0001645113-24-000002.txt   469278

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20240104.xsd EX-101.SCH 2001
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20240104_lab.xml EX-101.LAB 24055
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20240104_pre.xml EX-101.PRE 12579
9 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20240104_htm.xml XML 2707
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 24511939
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)